Allspring Global Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Allspring Global Investments's BMY Position: Q2 2026 in Review
Allspring Global Investments increased its Bristol-Myers Squibb (BMY) stake by 29% in Q2 2026, buying an estimated $18.1M and bringing the position to 1,410,480 shares worth $79.6M. The position accounts for 0.12% of the portfolio, ranked #192.
Allspring Global Investments first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $151M in Q4 2021. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Allspring Global Investments held 1,410,480 shares of Bristol-Myers Squibb worth $79.6M as of Q2 2026.
- Allspring Global Investments bought 314,826 Bristol-Myers Squibb shares in Q2 2026, an estimated $18.1M.
- Bristol-Myers Squibb made up 0.12% of Allspring Global Investments's portfolio in Q2 2026, its #192 holding.
- Allspring Global Investments first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Allspring Global Investments's Bristol-Myers Squibb position peaked at $151M in Q4 2021.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.